STRONGER warnings about the new diet pill Redux (dexfenfluramine)

September 1996

The FDA just came out with STRONGER warnings about the new diet pill Redux (dexfenfluramine).

The risk of primary pulmonary hypertension is about twice as high as originally thought...but still only about 35 cases per million.

But keep this in perspective. The benefits far outweigh the risks. Twenty times more people die from complications of obesity than from primary pulmonary hypertension.

Get concise, unbiased advice for effective drug therapy, plus CE/CME

Prescriber Insights: APRN includes:

  • Cutting-edge advice about new medications and how they fit into practice
  • Unbiased, evidence-based, 100% free of financial support from the pharma industry written by your peers
  • Side-by-side comparisons of drugs by class or disease state, plus FAQs, pros/cons, and simple recommendations

Already a subscriber? Log in

Volume pricing available. Get a quote